Allurion Technologies Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Public

  • Employees
  • 41

Employees

  • Stock Symbol
  • ALUR

Stock Symbol

  • Investments
  • 1

Allurion Technologies General Information

Description

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Contact Information

Formerly Known As
Elipse, SGL Medical, Allurion Technologies Holdings, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 6 Boulevard Montmartre
  • 75009 Paris
  • France
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Pharmaceuticals
Stock Exchange
OTCM
Corporate Office
  • 6 Boulevard Montmartre
  • 75009 Paris
  • France

Allurion Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allurion Technologies Stock Performance

As of 16-Nov-2026, Allurion Technologies’s current market cap is $1.28K with 608K shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.28K 608K 3.07K -$54.75

Allurion Technologies Financials Summary

As of 31-Mar-2026, Allurion Technologies has a trailing 12-month revenue of $12.6M.

In Thousands,
USD
TTM 31-Mar-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 33,748 42,374 40,017 158,740
Revenue 12,597 15,230 32,110 53,467
EBITDA (30,577) (27,698) (3,219) (71,241)
Net Income (33,349) (28,755) (7,198) (82,817)
Total Assets 13,995 15,772 32,813 71,712
Total Debt 29,446 29,039 37,923 41,857
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Allurion Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allurion Technologies‘s full profile, request access.

Request a free trial

Allurion Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Allurion Technologies‘s full profile, request access.

Request a free trial

Allurion Technologies Patents

Allurion Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12245962-B2 Balloon sealing and fill valve Active 12-Apr-2023
US-20250009540-A1 Balloon sealing and fill valve Active 12-Apr-2023
US-20250177177-A1 Balloon sealing and fill valve Active 12-Apr-2023
WO-2024215922-A1 Balloon sealing and fill valve Inactive 12-Apr-2023
WO-2021159094-A1 Fluid delivery catheter Inactive 07-Feb-2020 A61F5/003
To view Allurion Technologies’s complete patent history, request access »

Allurion Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allurion Technologies Acquisitions (1)

Allurion Technologies’s most recent deal was a Merger/Acquisition with Compute Health Acquisition. The deal was made on 01-Aug-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Compute Health Acquisition 01-Aug-2023 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Allurion Technologies’s complete acquisitions history, request access »

Allurion Technologies ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

38.1 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Allurion Technologies’s complete esg history, request access »

Allurion Technologies FAQs

  • When was Allurion Technologies founded?

    Allurion Technologies was founded in 2009.

  • Where is Allurion Technologies headquartered?

    Allurion Technologies is headquartered in Paris, France.

  • What is the size of Allurion Technologies?

    Allurion Technologies has 41 total employees.

  • What industry is Allurion Technologies in?

    Allurion Technologies’s primary industry is Therapeutic Devices.

  • Is Allurion Technologies a private or public company?

    Allurion Technologies is a Public company.

  • What is Allurion Technologies’s stock symbol?

    The ticker symbol for Allurion Technologies is ALUR.

  • What is the current market cap of Allurion Technologies?

    The current market capitalization of Allurion Technologies is $1.28K.

  • What is Allurion Technologies’s current revenue?

    The trailing twelve month revenue for Allurion Technologies is $12.6M.

  • What is Allurion Technologies’s annual earnings per share (EPS)?

    Allurion Technologies’s EPS for 12 months was -$54.75.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process